Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
- The Japanese biotechnology market recorded revenues of $30.8 billion in 2023, representing a compound annual growth rate (CAGR) of 11.3% between 2018 and 2023.
- The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $13.1 billion, equivalent to 42.7% of the market's overall value.
- The Japanese biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are also helping to drive growth in the industry. For instance, in June 2023, the Ministry of Economy, Trade, and Industry of Japan (METI) announced its plans to invest $3 billion to strengthen partnerships with the United States and support the biotech ecosystem.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Japan biotechnology market by value in 2023?
- What will be the size of the Japan biotechnology market in 2028?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Daiichi Sankyo Co Ltd
- Mitsubishi Tanabe Pharma Corporation
